Carbohydrate Strengthens the Immunotherapeutic Effect of Small-Molecule PD-L1 Inhibitors-Reference-Cited by-同舟云学术

Carbohydrate Strengthens the Immunotherapeutic Effect of Small-Molecule PD-L1 Inhibitors

Published:2023-05-25 Issue:11 Volume:66 Page:7179-7204
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Dong Qian¹²³,Tong Mengya²,Yu Xiaolu²,Wang Lei²,Ao Jiwei²,Guan Dongliang²^ORCID,Tang Yubo²,Liu Junjie²,Long Li²,Tong Yongliang²,Fang Shanhua²,Zhou Hu²³^ORCID,Huang Yongzhuo²³^ORCID,Gong Likun²³,Lou Liguang²³,Huang Wei¹²³^ORCID

Affiliation:

1. School of Pharmaceutical Science and Technology, Hangzhou Institute of Advanced Study, Hangzhou 310024, China

2. State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China

3. University of Chinese Academy of Sciences, Beijing 100049, China

Funder

Science and Technology Commission of Shanghai Municipality

National Natural Science Foundation of China

Hangzhou innovation and entrepreneurship leading team project

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.2c01347

Reference50 articles.

1. The future of immune checkpoint therapy

2. Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential

3. Cancer immunotherapy using checkpoint blockade

4. Cancer immunologists scoop medicine Nobel prize

5. Drug of the year: Programmed Death-1 receptor/Programmed Death-1 Ligand-1 receptor monoclonal antibodies

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of oligosaccharyl transglycosylation on the cytotoxicity of cardiac glycoside proscillaridin A and its ability to inhibit hepatitis B virus infection;2024-07-15

2. Targeting PD-1/PD-L-1 immune checkpoint inhibition for cancer immunotherapy: success and challenges;Frontiers in Immunology;2024-04-10

3. Recent advances and mechanisms of action of PD-L1 degraders as potential therapeutic agents;European Journal of Medicinal Chemistry;2024-03

4. Small molecule and PROTAC molecule experiments in vitro and in vivo, focusing on mouse PD-L1 and human PD-L1 differences as targets;Biomedicine & Pharmacotherapy;2024-03

5. Oncometabolite 2-hydroxyglutarate regulates anti-tumor immunity;Heliyon;2024-01